Current Issues in Transfusion Medicine is a newsletter written by physicians for physicians who deal with acquiring, preparing, and delivering transfused blood and blood products to patients. The newsletter is published triannually by the Section of Transfusion Medicine and Laboratory Immunology at The University of Texas M. D. Anderson Cancer Center. Though the issues covered arise specifically from our experience with transfusions in cancer patients at M. D. Anderson, these issues are also important to any physician involved with the transfusion of blood and blood products.

Blood Donor Screening for Infectious Diseases

• Normal Volunteer Granulocyte Donors: A Long-Term Follow-Up Study (Oct-Dec 2005)
• Human T-Lymphotropic Virus Types I and II: Screening and Seroprevalence in Blood Donors (Oct-Dec 1994)
• Human Immunodeficiency Virus Type 2: Implications for Blood Donors (Oct-Dec 1993)
• Blood Donor Screening and Prevention of Transfusion-Associated Hepatitis C Virus Infection (Jan-Mar 1993)

Pretransfusion (Serologic) Testing

• Laboratory Serologic Problems Associated with Administration of Intravenous IgG (Apr-Jun 1994)
• Pretransfusion Testing of Red Blood Cells: Current Status (Jan-Mar 1994)

Adverse Transfusion Reactions (Complications)

• Fresh Frozen Plasma Is Not a Cellular Blood Component: Transfusion Practice in Bone Marrow and Peripheral Blood Stem Cell Transplant Recipients (Jan-Apr 2004)
• Spontaneous Loss or Reactivation of Atypical RBC Alloantibodies in Cancer Patients (Jul-Sep 2002)
• Blood Transfusion in Patients Having Hematologic Malignancies and Solid Tumors: Problems Associated with AIHA and Unidentifiable RBC Alloantibodies (Sep-Dec 2001)
• Strategies for Preventing the Bacterial Contamination of Platelet Concentrates (Jan-Apr 1997)
• Nonhemolytic Transfusion Reaction to Platelet Concentrates: Induction by Cytokines Released during Storage (Jan-Apr 1995)
• Bacterial Contamination of Cellular Blood Components (Jul-Sep 1994)

Alternatives to Homologous (Allogeneic) Transfusion

• Directed/Designated Blood Donations: A Controversial Alternative in Transfusion Therapy (Jul-Sep 1993)
• Autologous Blood Deposits and Transfusions in Cancer Patients (Oct-Dec 1992)

Modified (or Specially Prepared) Blood Products

• A Simplified Method for Formalin Fixation and Batch Counting of Leukoreduced Blood Components (Jan-Apr 1998)
• Leukocyte-Reduced, Cytomegalovirus-Screened, and Irradiated Blood Components: Indications and Controversies (Apr-Jun 1993)

Issues in Bone Marrow Transplantation

• Hemolysis Following Allogeneic Bone Marrow Transplantation: Discussion and Analysis of a Case (Sep-Dec 1998)
• Thrombocytopenia Following Allogeneic Bone Marrow Transplantation: Discussion and Analysis of a Case (May-Aug 1998)

Return to M. D. Anderson Cancer Center home page

Last updated November 2, 2005